Author

Madan Maitre

Observed names: M P Maitre, M. Maitre, M. P. Maitre

Institution: Peter MacCallum Cancer Centre

Observed institutions: Homi Bhabha National Institute, Tata Memorial Hospital, Peter MacCallum Cancer Centre, Advanced Centre for Treatment, Research and Education in Cancer

ORCID: 0000-0003-1280-7584

Observed ORCID: 0000-0003-1280-7584

OpenAlex ID: A5046338804

Hippocampal radiotherapy dose constraints for predicting long-term neurocognitive outcomes: mature data from a prospective trial in young patients with brain tumors

2020 · Jayant S Goda, Debnarayan Dutta, et al. · Neuro-Oncology · 67

Dose-Constraint Model to Predict Neuroendocrine Dysfunction in Young Patients With Brain Tumors: Data From a Prospective Study

2019 · Rakesh Jalali, Madan Maitre, et al. · Practical Radiation Oncology · 7

Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma

2022 · Archya Dasgupta, Tejpal Gupta, et al. · Strahlentherapie und Onkologie · 3

Advanced diffusion MRI tractography for radiotherapy planning in pediatric brain tumors: A feasibility study

2026 · Madan Maitre, Adam Yeo, et al. · Physics and Imaging in Radiation Oncology

High-dose salvage re-irradiation in recurrent/progressive adult diffuse gliomas: development of a novel prognostic scoring system

2022 · Tejpal Gupta, Madan Maitre, et al. · WFNOS 2022 Abstract Book

Embr-14. Influence of Mri Features on the Survival and Impact on Individual Molecular Subgroups: Result From 171 Patients With Medulloblastoma

2021 · Archya Dasgupta, Madan Maitre, et al. · Neuro-Oncology

PO-139: Cushing’s disease outcomes with conventional fractionated modern stereotactic conformal or IM-IGRT

2019 · R. krishnatry, M. Maitre, et al. · Radiotherapy and Oncology

P05.13 Long term clinical outcomes with helical tomotherapy based image guided intensity modulated radiotherapy for benign and low grade brain tumours

2018 · M P Maitre, T Gupta, et al. · Neuro-Oncology

Ronc-17. Does the Efficacy of Salvage Re-irradiation in Recurrent Medulloblastoma Depend Upon Risk-stratification, Site of Relapse, and Molecular Subgroup?

2018 · Tejpal Gupta, Madan Maitre, et al. · Neuro-Oncology

OS02.7 Dose constraint model to predict neuroendocrine dysfunction in young patients with brain tumours- Data from a prospective study of stereotactic conformal radiotherapy

2017 · M. P. Maitre, T. Gupta, et al. · Neuro-Oncology

Works count: 10

Citation count: 77

H-index: 3

I10-index: 1